Augmentin '125' and Thalomid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Thalomid (thalidomide). Common drug interactions include urinary tract infection among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Thalomid. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.



On Aug, 06, 2026

41 people who take Augmentin '125' and Thalomid together, and have interactions are studied.

Augmentin '125' and Thalomid drug interactions.

What are the common drug interactions of Augmentin '125' and Thalomid, by gender? *:

female:

  1. Urinary tract infection
  2. Weight decreased
  3. Blepharitis (chronic inflammation of the eyelid)
  4. Bone neoplasm (tumour of bone)
  5. Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
  6. Skin erosion (a discontinuity of the skin)
  7. Spinal column stenosis (narrowing of spinal column)
  8. Abasia (inability to walk)
  9. Decreased appetite
  10. Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli)

male:

  1. Pneumonia
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Venoocclusive disease (small veins in the liver are obstructed)
  6. Pyrexia (fever)
  7. Anaemia (lack of blood)
  8. Disease progression
  9. Constipation
  10. Diarrhoea

What are the common drug interactions of Augmentin '125' and Thalomid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Arthralgia (joint pain)
  2. Cardiac arrest
  3. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Haemoglobin decreased
  6. Joint swelling
  7. Platelet count increased
  8. Pyrexia (fever)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Sudden death

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Constipation
  3. Diarrhoea
  4. Disease progression
  5. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  6. Neoplasm recurrence (reoccurrence of tumour)
  7. Neuropathy peripheral (surface nerve damage)
  8. Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
  9. Spinal compression fracture (fracture due to spinal compression on bone)
  10. Spinal cord compression

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Death
  3. Disease progression
  4. Metastases to lung (cancer spreads to lung)
  5. Pleural effusion (water on the lungs)

50-59:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Bone disorder
  5. Deafness
  6. Deformity (disfigurement)
  7. Depression
  8. Disability
  9. Dyspepsia (indigestion)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Asthenia (weakness)
  3. Blood creatine phosphokinase increased
  4. Blood immunoglobulin a increased
  5. Bone disorder
  6. Bruxism (habitual grinding of the teeth, typically during sleep)
  7. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  8. Cardiac disorder
  9. Cardiac failure congestive
  10. Carotid artery stenosis (narrowing of carotid artery)

What are the existing conditions these people have? *

  1. Light Chain Analysis Increased: 12 people, 29.27%
  2. Pain: 10 people, 24.39%
  3. Metastases To Bone (cancer spreads to bone): 8 people, 19.51%
  4. Neoplasm Malignant (cancer tumour): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Thalomid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalomid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and thalidomide (the active ingredients of Augmentin '125' and Thalomid, respectively), and Augmentin '125' and Thalomid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: